Exact Mass: 740.2784423999999

Exact Mass Matches: 740.2784423999999

Found 44 metabolites which its exact mass value is equals to given mass value 740.2784423999999, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Odevixibat

(2S)-2-(((2R)-2-((((3,3-Dibutyl-7-(methylsulfanyl)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepin-8-yl)oxy)acetyl)amino)-2-(4-hydroxyphenyl)acetyl)amino)butanoic acid

C37H48N4O8S2 (740.2913408000001)

C78276 - Agent Affecting Digestive System or Metabolism > C177170 - Ileal Bile Acid Transport Inhibitor A - Alimentary tract and metabolism > A05 - Bile and liver therapy > A05A - Bile therapy

(5S)-5-hydroxy-1,7-bis-(4-hydroxyphenyl)-3-heptanone-5-O-[2,6-bis-O-(beta-D-apiofuranosyl)-beta-D-glucopyranoside]

C35H48O17 (740.2891357999999)

C36H52O16

C36H52O16 (740.3255192)

2alpha,7beta,9alpha,10beta-13alpha-pentaacetoxy-5alpha-cinnamoyloxy-4beta,20-epoxy-taxa-11-en-1beta-ol

C39H48O14 (740.3043908)

C34H44O18

C34H44O18 (740.2527524)

8-methoxyhypophyllanthin-2a-O-beta-apiofuranosyl-(1->6)-O-beta-glucopyranoside

C35H48O17 (740.2891357999999)

Swietephragmin B

C39H48O14 (740.3043908)

(+)-jasplakinolide Z5

C36H45BrN4O8 (740.242059)

A depsipeptide isolated from Jaspis splendens.

(+)-jasplakinolide Z2

C37H49BrN4O7 (740.2784423999999)

A depsipeptide isolated from Jaspis splendens.

Cladochrome B

C41H40O13 (740.246879)

7-O-acetyl-5-O-benzoyl-13,15-dihydroxy-3,18-O-dinicotinoyl-14-oxo-lathyrane

C41H44N2O11 (740.2944954000001)

angoroside A

C34H44O18 (740.2527524)

piperazimycin C

C32H49ClN8O10 (740.3260004000001)

C34H44O18

NCGC00380919-01_C34H44O18_

C34H44O18 (740.2527524)

Ferrichrome

C27H42FeN9O12 (740.2302182)

A member of the class of ferrichromes that is an iron(III) chelate of a homodetic cyclic peptide made up of a tripeptide of glycine and a tripeptide of N(4)-acetyl-N(4)-hydroxy-L-ornithine.

3-O-(4-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)-3beta,14beta,16beta-trihydroxy-19-oxo-5alpha-bufa-20,22-dienolide

C36H52O16 (740.3255192)

[1,1:4,1:4,1-Quaterphenyl]-4,4-diamine, N4,N4-di-1-naphthalenyl-N4,N4-diphenyl

C56H40N2 (740.3191320000001)

4,4,4-Tris(carbazol-9-yl)-triphenylamine

C54H36N4 (740.2939815999999)

N,N-Di-1-naphthalenyl-N,N-diphenyl-[quaterphenyl]-4,4-diamine

C56H40N2 (740.3191320000001)

(Ile3)-Pressinoic acid

C30H44N8O10S2 (740.2621684000001)

Odevixibat

C37H48N4O8S2 (740.2913408000001)

C78276 - Agent Affecting Digestive System or Metabolism > C177170 - Ileal Bile Acid Transport Inhibitor A - Alimentary tract and metabolism > A05 - Bile and liver therapy > A05A - Bile therapy

(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, hemihydrate

C36H42F2N6O9 (740.2981186000001)

D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Nannochelin C

C36H44N4O13 (740.2904734)

dimethyl-[(1S,10S,12S,13R,21S,23S)-4,8,12-trihydroxy-10-[(2R,3R,4R,5S,6S)-4-hydroxy-3,5-dimethoxy-4,6-dimethyloxan-2-yl]oxy-13-methoxycarbonyl-1,12-dimethyl-6,17-dioxo-25-oxahexacyclo[19.3.1.02,19.05,18.07,16.09,14]pentacosa-2,4,7(16),8,14,18-hexaen-23-yl]azanium

dimethyl-[(1S,10S,12S,13R,21S,23S)-4,8,12-trihydroxy-10-[(2R,3R,4R,5S,6S)-4-hydroxy-3,5-dimethoxy-4,6-dimethyloxan-2-yl]oxy-13-methoxycarbonyl-1,12-dimethyl-6,17-dioxo-25-oxahexacyclo[19.3.1.02,19.05,18.07,16.09,14]pentacosa-2,4,7(16),8,14,18-hexaen-23-yl]azanium

C39H50NO13+ (740.3281989999999)

1-[[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

1-[[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

C34H43F3N4O7S2 (740.2525124000001)

benzyl beta-D-glucopyranuronosyl-(1->3)-beta-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-beta-D-xylopyranoside

C30H44O21 (740.2374973999999)

LPIM1 17:4

C32H53O17P (740.3020217999999)

PI 20:5/7:3;O

C36H53O14P (740.3172768)

PI 27:8;O

C36H53O14P (740.3172768)

(5r,6r)-9-[(2r,4r,5r,6r)-4-{[(2s,5s,6s)-5-{[(2s,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]-1,8-dihydroxy-5,6-dimethoxy-3-methyl-5,6-dihydrotetraphene-7,12-dione

(5r,6r)-9-[(2r,4r,5r,6r)-4-{[(2s,5s,6s)-5-{[(2s,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]-1,8-dihydroxy-5,6-dimethoxy-3-methyl-5,6-dihydrotetraphene-7,12-dione

C39H48O14 (740.3043908)

(2s)-2-{[3-carboxy-3-({[(1s)-1-carboxy-5-[(2e)-n-hydroxy-3-phenylprop-2-enamido]pentyl]-c-hydroxycarbonimidoyl}methyl)-1,3-dihydroxypropylidene]amino}-6-[(2e)-n-hydroxy-3-phenylprop-2-enamido]hexanoic acid

(2s)-2-{[3-carboxy-3-({[(1s)-1-carboxy-5-[(2e)-n-hydroxy-3-phenylprop-2-enamido]pentyl]-c-hydroxycarbonimidoyl}methyl)-1,3-dihydroxypropylidene]amino}-6-[(2e)-n-hydroxy-3-phenylprop-2-enamido]hexanoic acid

C36H44N4O13 (740.2904734)

(2s)-1-{[(1r,4s,4as,5s,6s,8ar)-4,5-dihydroxy-6-(3-methoxy-3-oxoprop-1-en-2-yl)-8a-methyl-4-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-octahydronaphthalen-1-yl]oxy}-3-(4-hydroxyphenyl)-1-oxopropan-2-yl (2r)-2-hydroxy-3-methylbutanoate

(2s)-1-{[(1r,4s,4as,5s,6s,8ar)-4,5-dihydroxy-6-(3-methoxy-3-oxoprop-1-en-2-yl)-8a-methyl-4-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-octahydronaphthalen-1-yl]oxy}-3-(4-hydroxyphenyl)-1-oxopropan-2-yl (2r)-2-hydroxy-3-methylbutanoate

C36H52O16 (740.3255192)

6-{[(4r,5s,6r,8s,9s,16s,18s)-6-(dimethoxymethyl)-4,5,6,9,18,21-hexahydroxy-5-(hydroxymethyl)-14-methoxy-11-methyl-19-oxo-3,7-dioxapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-1,10,12,14,20-pentaen-16-yl]oxy}-4-hydroxy-2,4-dimethyloxan-3-yl acetate

6-{[(4r,5s,6r,8s,9s,16s,18s)-6-(dimethoxymethyl)-4,5,6,9,18,21-hexahydroxy-5-(hydroxymethyl)-14-methoxy-11-methyl-19-oxo-3,7-dioxapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-1,10,12,14,20-pentaen-16-yl]oxy}-4-hydroxy-2,4-dimethyloxan-3-yl acetate

C34H44O18 (740.2527524)

(2s,3r,4r,5r,6s)-5-(acetyloxy)-4-hydroxy-6-{[(1s,2s,4s,5s,6r,10s)-2-(hydroxymethyl)-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl]oxy}-2-methyloxan-3-yl (2e)-3-(3,4-dimethoxyphenyl)prop-2-enoate

(2s,3r,4r,5r,6s)-5-(acetyloxy)-4-hydroxy-6-{[(1s,2s,4s,5s,6r,10s)-2-(hydroxymethyl)-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl]oxy}-2-methyloxan-3-yl (2e)-3-(3,4-dimethoxyphenyl)prop-2-enoate

C34H44O18 (740.2527524)